Surgical management of valvular heart disease ppt
Surgical management of valvular heart disease ppt Surgical management of valvular heart disease is a critical aspect of cardiology and cardiothoracic surgery, aimed at restoring normal heart function and improving patient outcomes. Valvular heart diseases, which include stenosis (narrowing of valves) and regurgitation (leakage of valves), can significantly impair cardiac efficiency, leading to symptoms such as breathlessness, fatigue, and heart failure. When medical management fails or the disease progresses to an advanced stage, surgical intervention becomes necessary.
The primary surgical options for valvular heart disease include valve repair and valve replacement. Valve repair involves reconstructing the patient’s own valve to restore its normal function. This approach is preferred when feasible because it preserves the native valve, maintains the natural tissue, and often results in better long-term outcomes. Techniques used in repair procedures may include annuloplasty (tightening or reinforcing the valve annulus), resection of diseased tissue, chordal transfer, or leaflet augmentation. The success of repair largely depends on the type and extent of valve pathology, with mitral valve repair being more common and successful than aortic valve repair.
Valve replacement is indicated when repair is not possible or unlikely to succeed. This involves removing the diseased valve and substituting it with a prosthetic valve. Prosthetic valves are broadly categorized into mechanical and bioprosthetic (tissue) valves. Mechanical valves are durable and suitable for younger patients but require lifelong anticoagulation due to their thrombogenic nature. Bioprosthetic valves, made from animal tissue, tend to have a limited lifespan but generally do not require long-term anticoagulation, making them preferable for older patients or those with contraindications to anticoagulation therapy.
Surgical techniques for valve replacement are performed via open-heart surgery, typically through a median sternotomy, although minimally invasive approaches are increasingly being utilized. The procedure involves cardiopulmonary bypass, which temporarily takes over the function of the heart and lungs, allowing the surgeon to operate on a still and bloodless field. After excising the diseased valve, the prosthetic valve is sewn into place meticulously to ensure proper seating and function. Postoperative management includes anticoagulation therapy, especially for mechanical valves, to prevent thromboembolic events.
In recent years, transcatheter valve therapies have emerged as less invasive alternatives to traditional open surgery, especially for high-risk patients. Transcatheter Aortic Valve Replacement (TAVR) is now a standard treatment for certain patients with severe aortic stenosis, providing a viable option for those who are deemed inoperable or high-risk candidates.
Overall, the surgical management of valvular heart disease requires precise diagnosis, careful patient selection, and skilled surgical execution. Long-term follow-up is crucial to monitor valve function, prevent complications, and ensure optimal quality of life for patients.
